オキシコドン塩酸塩の世界市場レポート2025年

オキシコドン塩酸塩の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.7％で50億1,000万米ドルに成長します。この将来的な成長の促進要因としては、慢性疼痛症例の持続的な増加、術後介入の増加傾向、より広範ながん診断、高齢者層の継続的な増加、整形外科的合併症の発生増加などが予想されます。予測期間中に予想される先進パッケージングの動向には、乱用抑止技術の進歩、徐放性製剤の処方、個別化治療のための薬理遺伝学の統合、改ざん防止包装の革新、放出制御型ドラッグデリバリーシステムの改良などが含まれます。

慢性疼痛の有病率の上昇は、オキシコドン塩酸塩市場の成長を促進すると予想されます。慢性疼痛とは、3カ月以上持続し、怪我や病気の典型的な治癒期間を超えて継続する痛みと定義されます。このような痛みの増加は主に肥満の増加によるもので、体重が増えすぎると関節や筋肉に負担がかかり、変形性関節症や腰痛などの症状を引き起こします。オキシコドン塩酸塩は、神経系の疼痛受容体をターゲットにすることで、中等度から重度の疼痛を効果的に緩和し、患者の快適性と全体的な生活の質を向上させ、慢性疼痛管理をサポートします。例えば、2023年3月、英国政府機関であるOffice for Health Improvement and Disparitiesは、16歳以上の個人の17.6％が2022年には関節炎や持続的な背中や関節の問題などの長期的な筋骨格系の状態にあり、2021年の17.0％から増加していると報告しました。この動向は、慢性疼痛の有病率の増加がオキシコドン塩酸塩の市場成長に寄与していることを裏付けています。

オキシコドン塩酸塩市場の主なプレーヤーは、オピオイド依存のリスクを軽減しながら疼痛管理を改善するため、併用療法を含む先進製品の開発に注力しています。併用療法は、2種類以上の薬剤を併用することで、治療効果を高めたり、複数の作用機序をターゲットにしたり、耐性リスクを低下させたりするものです。例えば、2025年4月、米国の製薬会社Elite Pharmaceuticals Inc.は、ペルコセットのジェネリック医薬品（オキシコドン塩酸塩およびアセトアミノフェン錠、USP CII）を発売しました。この製品は、3つの強さ-mg/325mg、10mg/325mg、325mg錠があり、中等度から中等度の痛みを和らげるために使用されます。この製剤は、強力な鎮痛効果のあるオキシコドンに、鎮痛効果を高めるアセトアミノフェンを配合したものです。スケジュールⅡの規制薬物として、乱用と依存の可能性が高いため、厳格な医学的監視が必要です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のオキシコドン塩酸塩：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のオキシコドン塩酸塩市場：成長率分析
• 世界のオキシコドン塩酸塩市場の実績：規模と成長, 2019-2024
• 世界のオキシコドン塩酸塩市場の予測：規模と成長, 2024-2029, 2034F
• 世界のオキシコドン塩酸塩：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のオキシコドン塩酸塩市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐放錠
• 即放錠
• 経口溶液
• 徐放性カプセル
• 世界のオキシコドン塩酸塩市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 保護者
• 世界のオキシコドン塩酸塩市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 手術後の痛み
• がん関連の痛み
• 世界のオキシコドン塩酸塩市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のオキシコドン塩酸塩市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• ホームケア
• 世界のオキシコドン塩酸塩市場徐放錠の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乱用抑止製剤
• 乱用抑止効果のない製剤
• 世界のオキシコドン塩酸塩市場、即放錠の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み合わせ製品
• 単剤製剤
• 世界のオキシコドン塩酸塩市場経口液のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 濃縮溶液
• 標準ソリューション
• 世界のオキシコドン塩酸塩市場徐放性カプセルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 改ざん防止カプセル
• ジェネリック医薬品

第7章 地域別・国別分析

• 世界のオキシコドン塩酸塩市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオキシコドン塩酸塩市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オキシコドン塩酸塩市場：競合情勢
• オキシコドン塩酸塩市場：企業プロファイル
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Daiichi Sankyo Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Endo Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lupin Ltd
• Mallinckrodt Pharmaceuticals Inc.
• Euroapi SA
• Ani Pharmaceuticals Inc.
• Purdue Pharma LLP
• Chattem Chemicals Inc.
• Mayne Pharma Group Limited
• Alvogen Inc.
• Veranova
• Temad Co.
• Camber Pharmaceuticals
• Noramco Inc.
• Saneca Pharma A.S.
• Rhodes Pharmaceuticals
• Arevipharma GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オキシコドン塩酸塩市場2029：新たな機会を提供する国
• オキシコドン塩酸塩市場2029：新たな機会を提供するセグメント
• オキシコドン塩酸塩市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oxycodone hydrochloride is a potent opioid analgesic used to relieve moderate to severe pain. It works by binding to opioid receptors in the brain and spinal cord to reduce the perception of pain. It is frequently prescribed for managing pain following surgery or injury and for long-term conditions that involve chronic pain.

The primary forms of oxycodone hydrochloride include extended-release tablets, immediate-release tablets, oral solutions, and extended-release capsules. Extended-release tablets are formulated to gradually release the drug over an extended period, ensuring consistent therapeutic levels and minimizing the need for frequent dosing. This medication can be administered orally or through parenteral routes and is widely used to treat various types of pain, such as pain resulting from surgery or cancer. It is distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and is utilized across various settings such as hospitals, clinics, and home care environments.

The oxycodone hydrochloride market research report is one of a series of new reports from The Business Research Company that provides oxycodone hydrochloride market statistics, including the oxycodone hydrochloride industry's global market size, regional shares, competitors with the oxycodone hydrochloride market share, detailed oxycodone hydrochloride market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone hydrochloride market. This oxycodone hydrochloride market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The oxycodone hydrochloride market size has grown steadily in recent years. It will grow from $4.15 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The historical growth was influenced by an increasing prevalence of chronic pain conditions, a higher volume of surgical procedures, a surge in cancer diagnoses, an expanding aging population, and the escalating incidence of orthopedic ailments.

The oxycodone hydrochloride market size is expected to see steady growth in the next few years. It will grow to $5.01 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. Anticipated drivers of this future growth include the persistent rise in chronic pain cases, an uptrend in post-surgical interventions, more widespread cancer diagnoses, continued growth in the elderly demographic, and a greater occurrence of orthopedic complications. Prominent trends expected during the forecast period encompass the advancement of abuse-deterrent technologies, formulation of extended-release options, integration of pharmacogenomics for personalized treatment, tamper-resistant packaging innovations, and improvements in controlled-release drug delivery systems.

The rising prevalence of chronic pain is anticipated to drive the growth of the oxycodone hydrochloride market. Chronic pain is defined as pain that persists for more than three months and continues beyond the typical healing time of an injury or illness. This growing prevalence is mainly due to increasing rates of obesity, as excess body weight places additional pressure on joints and muscles, leading to conditions such as osteoarthritis and lower back pain. Oxycodone hydrochloride supports chronic pain management by delivering effective relief from moderate to severe pain, improving patient comfort and overall quality of life by targeting pain receptors in the nervous system. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that 17.6% of individuals aged 16 and over had a long-term musculoskeletal condition such as arthritis or persistent back or joint problems in 2022, up from 17.0% in 2021. This trend underscores how the increasing prevalence of chronic pain is contributing to the market growth of oxycodone hydrochloride.

Key players in the oxycodone hydrochloride market are concentrating on the development of advanced products, including combination therapies, to improve pain management while mitigating the risk of opioid dependency. Combination therapies involve using two or more medications together to boost treatment effectiveness, target multiple mechanisms of action, or lower the risk of resistance. For instance, in April 2025, Elite Pharmaceuticals Inc., a US-based pharmaceutical firm, launched a generic version of Percocet (oxycodone hydrochloride and acetaminophen tablets, USP CII). This product is available in three strengths-mg/325 mg, 10 mg/325 mg, and 325 mg tablets-and is used to relieve moderate to moderately severe pain. The formulation combines oxycodone for strong pain relief with acetaminophen to enhance analgesic efficacy. As a Schedule II controlled substance, it has a high potential for abuse and dependence and thus requires strict medical oversight.

In June 2024, Elite Pharmaceuticals Inc., a US-based pharmaceutical company, entered a partnership with Nostrum Laboratories Inc. to acquire three approved abbreviated new drug applications (ANDAs) for generic versions of Norco, Percocet, and Dolophine. This collaboration seeks to broaden their range of generic opioid analgesics, strengthen their presence in pain management, and provide patients with more affordable alternatives to branded pain relief medications. Nostrum Laboratories Inc. is a US-based company that manufactures prescription medications, including an oral solution that combines oxycodone hydrochloride and acetaminophen.

Major players in the oxycodone hydrochloride market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Lupin Ltd, Mallinckrodt Pharmaceuticals Inc., Euroapi SA, Ani Pharmaceuticals Inc., Purdue Pharma LLP, Chattem Chemicals Inc., Mayne Pharma Group Limited, Alvogen Inc., Veranova, Temad Co., Camber Pharmaceuticals, Noramco Inc., Saneca Pharma A.S., Rhodes Pharmaceuticals, and Arevipharma GmbH.

North America was the largest region in the oxycodone hydrochloride market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oxycodone hydrochloride report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oxycodone hydrochloride market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oxycodone hydrochloride market consists of sales of oxycodone injectable formulations, oxycodone nasal sprays, oxycodone suppositories, and percocet. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxycodone Hydrochloride Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oxycodone hydrochloride market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oxycodone hydrochloride ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxycodone hydrochloride market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Extended Release Tablets; Immediate Release Tablets; Oral Solutions; Extended Release Capsules
• 2) By Route Of Administration: Oral; Parental
• 3) By Application: Pain Management; Post Surgical Pain; Cancer Related Pain
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Clinics; Homecare
• Subsegments:
• 1) By Extended Release Tablets: Abuse-Deterrent Formulations; Non-Abuse-Deterrent Formulations
• 2) By Immediate Release Tablets: Combination Products; Single-Agent Formulations
• 3) By Oral Solutions: Concentrated Solutions; Standard Solutions
• 4) By Extended Release Capsules: Tamper-Resistant Capsules; Generic Formulations
• Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company Ltd.; Sun Pharmaceutical Industries Ltd.; Endo Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oxycodone Hydrochloride Market Characteristics

3. Oxycodone Hydrochloride Market Trends And Strategies

4. Oxycodone Hydrochloride Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Oxycodone Hydrochloride Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oxycodone Hydrochloride PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oxycodone Hydrochloride Market Growth Rate Analysis
• 5.4. Global Oxycodone Hydrochloride Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oxycodone Hydrochloride Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oxycodone Hydrochloride Total Addressable Market (TAM)

6. Oxycodone Hydrochloride Market Segmentation

• 6.1. Global Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended Release Tablets
• Immediate Release Tablets
• Oral Solutions
• Extended Release Capsules
• 6.2. Global Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parental
• 6.3. Global Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Post Surgical Pain
• Cancer Related Pain
• 6.4. Global Oxycodone Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Oxycodone Hydrochloride Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• 6.6. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Extended Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Abuse-Deterrent Formulations
• Non-Abuse-Deterrent Formulations
• 6.7. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Immediate Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Products
• Single-Agent Formulations
• 6.8. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Oral Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Concentrated Solutions
• Standard Solutions
• 6.9. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Extended Release Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tamper-Resistant Capsules
• Generic Formulations

7. Oxycodone Hydrochloride Market Regional And Country Analysis

• 7.1. Global Oxycodone Hydrochloride Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oxycodone Hydrochloride Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oxycodone Hydrochloride Market

• 8.1. Asia-Pacific Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oxycodone Hydrochloride Market

• 9.1. China Oxycodone Hydrochloride Market Overview
• 9.2. China Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oxycodone Hydrochloride Market

• 10.1. India Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oxycodone Hydrochloride Market

• 11.1. Japan Oxycodone Hydrochloride Market Overview
• 11.2. Japan Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oxycodone Hydrochloride Market

• 12.1. Australia Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oxycodone Hydrochloride Market

• 13.1. Indonesia Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oxycodone Hydrochloride Market

• 14.1. South Korea Oxycodone Hydrochloride Market Overview
• 14.2. South Korea Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oxycodone Hydrochloride Market

• 15.1. Western Europe Oxycodone Hydrochloride Market Overview
• 15.2. Western Europe Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oxycodone Hydrochloride Market

• 16.1. UK Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oxycodone Hydrochloride Market

• 17.1. Germany Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oxycodone Hydrochloride Market

• 18.1. France Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oxycodone Hydrochloride Market

• 19.1. Italy Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oxycodone Hydrochloride Market

• 20.1. Spain Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oxycodone Hydrochloride Market

• 21.1. Eastern Europe Oxycodone Hydrochloride Market Overview
• 21.2. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oxycodone Hydrochloride Market

• 22.1. Russia Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oxycodone Hydrochloride Market

• 23.1. North America Oxycodone Hydrochloride Market Overview
• 23.2. North America Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oxycodone Hydrochloride Market

• 24.1. USA Oxycodone Hydrochloride Market Overview
• 24.2. USA Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oxycodone Hydrochloride Market

• 25.1. Canada Oxycodone Hydrochloride Market Overview
• 25.2. Canada Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oxycodone Hydrochloride Market

• 26.1. South America Oxycodone Hydrochloride Market Overview
• 26.2. South America Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oxycodone Hydrochloride Market

• 27.1. Brazil Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oxycodone Hydrochloride Market

• 28.1. Middle East Oxycodone Hydrochloride Market Overview
• 28.2. Middle East Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oxycodone Hydrochloride Market

• 29.1. Africa Oxycodone Hydrochloride Market Overview
• 29.2. Africa Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oxycodone Hydrochloride Market Competitive Landscape And Company Profiles

• 30.1. Oxycodone Hydrochloride Market Competitive Landscape
• 30.2. Oxycodone Hydrochloride Market Company Profiles
  • 30.2.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Daiichi Sankyo Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Endo Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Oxycodone Hydrochloride Market Other Major And Innovative Companies

• 31.1. Lupin Ltd
• 31.2. Mallinckrodt Pharmaceuticals Inc.
• 31.3. Euroapi SA
• 31.4. Ani Pharmaceuticals Inc.
• 31.5. Purdue Pharma LLP
• 31.6. Chattem Chemicals Inc.
• 31.7. Mayne Pharma Group Limited
• 31.8. Alvogen Inc.
• 31.9. Veranova
• 31.10. Temad Co.
• 31.11. Camber Pharmaceuticals
• 31.12. Noramco Inc.
• 31.13. Saneca Pharma A.S.
• 31.14. Rhodes Pharmaceuticals
• 31.15. Arevipharma GmbH

32. Global Oxycodone Hydrochloride Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oxycodone Hydrochloride Market

34. Recent Developments In The Oxycodone Hydrochloride Market

35. Oxycodone Hydrochloride Market High Potential Countries, Segments and Strategies

• 35.1 Oxycodone Hydrochloride Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oxycodone Hydrochloride Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oxycodone Hydrochloride Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer